Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Safety and Persistence of Effectiveness of Manualized MDMA-Assisted Therapy for the Treatment of Posttraumatic Stress Disorder

NCT05066282 is registered in ClinicalTrials.gov with Resilient Pharmaceuticals as lead sponsor.

NCT NCT05066282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05066282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Safety and Persistence of Effectiveness of Manualized MDMA-Assisted Therapy for the Treatment of Posttraumatic Stress Disorder
Lead sponsor
Resilient Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
March 1, 2021
Completion date
May 21, 2024
Enrollment
186 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ptsd